Does palliative home oxygen improve dyspnoea? A consecutive cohort study

Abstract

Palliative oxygen for refractory dyspnoea is frequently prescribed, even when the criteria for long-term home oxygen (based on survival, rather than the symptomatic relief of breathlessness) are not met. Little is known about how palliative home oxygen affects symptomatic breathlessness. A 4 -year consecutive cohort from a regional community palliative care service in Western Australia was used to compare baseline breathlessness before oxygen therapy with dyspnoea sub-scales on the symptom assessment scores (SAS; 0–10) 1 and 2 weeks after the introduction of oxygen. Demographic and clinical characteristics of people who responded were included in a multi-variable logistic regression model. Of the study population (n = 5862), 21.1% (n = 1239) were prescribed oxygen of whom 413 had before and after data that could be included in this analysis. The mean breathlessness before home oxygen was 5.3 (SD 2.5; median 5; range 0–10). There were no significant differences overall at 1 or 2 weeks (P = 0.28) nor for any diagnostic sub-groups. One hundred and fifty people (of 413) had more than a 20% improvement in mean dyspnoea scores. In multi-factor analysis, neither the underlying diagnosis causing breathlessness nor the demographic factors predicted responders at 1 week. Oxygen prescribed on the basis of breathlessness alone across a large population predominantly with cancer does not improve breathlessness for the majority of people. Prospective randomised trials in people with cancer and non-cancer are needed to determine whether oxygen can reduce the progression of breathlessness compared to a control arm.

Keywords

dyspnoea care oxygen inhalational therapy palliative respiratory respiratory system signs and symptoms

Get full access to this article

View all access options for this article.

References

1 Reuben D Mor V . Dyspnea in terminally ill cancer patients. Chest 1986; 89: 234–236.

2 Bruera E Scmitz B Pither J Neumann C Hanson J . The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage 2000; 19: 357–362.

3 Dudgeon D Kristjanson L Lertzman M Clement K . Dyspnoea in cancer patients. prevalence and associated factors. J Pain Symptom Manage 2001; 21: 95–102.

4 Caprio A Hanson L Munn J . Pain, dyspnea, and the quality of dying in long-term care. J Am Geriatr Soc 2008; 56: 683–688.

5 Ripamonti C . Management of dyspnea in advanced cancer patients. Support Care Cancer 1999; 7: 233–243.

6 Quinten C Coens C Mauer M Comte S Sprangers M Cleeland C . Quality of life predictors of prognosis. An evaluation of EORTC studies. J Clin Oncol 2008; 20(Suppl.) [abstract 9516].

7 Abernethy AP Currow DC Frith P Fazekas BS McHugh A Bui C . Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003; 327: 523–528.

8 Tanaka K Akechi T Okuyama T Nishiwaki Y Uchitomi Y . Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage 2002; 23: 484–489.

9 Booth S Moosavi SH Higginson IJ . The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. Nat Clin Pract Oncol 2008; 5: 90–100.

10.

10 Bredin M Corner J Krishnasamy M Plant H Bailey C A'Hern R . Multi-center randomized controlled trial of nursing intervention for breathlessness in patients with lung cancer. Br Med J 1999; 318: 901–904.

11.

11 Corner J Plant H A'Hern R Bailey C . Non-pharmacological intervention for breathlessness in lung cancer. Palliat Med 1996; 10: 299–305.

12.

12 Guell R Casan P Belda J Sangenis M Morante F Guyatt GH . Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 2000; 117: 976–983.

13.

13 Hately J Laurence V Scott A Baker R Thomas P . Breathlessness clinics within specialist palliative care settings can improve the quality of life and functional capacity of patients with lung cancer. Palliat Med 2003; 17: 410–417.

14.

14 Jennings AL Davies AN Higgins JPT Gibbs JSR Broadley KE . A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002; 57: 939–944.

15.

15 Lacasse Y Wong E Guyatt GH . Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348: 1115–1119.

16.

16 Lambert A . Adult domiciliary oxygen therapy: a patient's perspective. Med J Aust 2005; 183: 472–473.

17.

17 Nonoyama M Brooks D Guyatt GH Goldstein R . Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med 2007; 176: 343–349.

18.

18 Uronis HE Currow DC McCrory DC Samsa GP Abernethy AP . Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer 2008; 98: 294–299.

19.

19 McDonald C Crockett A Young I . Domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia. Med J Aust 2005; 182: 621–626.

20.

20 Booth S Wade R Johnson M Kite S Swannick M Anderson H . The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med 2004; 98: 66–77.

21.

21 Guyatt GH Mckim D Austin P Bryan R Norgren J Weaver B . Appropriateness of domiciliary oxygen delivery. Chest 2000; 118: 1303–1308.

22.

22 Jones A Richard Wood-Baker R Walters E . Domiciliary oxygen therapy services in Tasmania: prescription, usage and impact of a specialist clinic. Med J Aust 2007; 186: 632–634.

23.

23 Kristjanson L; Pickstock S; Yuen K; Davis S; Blight J; Cummins A; . Development and testing of the revised Symptom Assessment Scale (SAS). Perth, Western Australia: Edith Cowan University, 1999.

24.

24 Bailey PH . The dyspnea-anxiety-dyspnea cycle – COPD patients' stories of breathlessness: “It's scary/when you can't breathe”. Qual Health Res 2004; 14: 760–778.

25.

25 Bausewein C Farquhar M Booth S Gysels M Higginson IJ . Measurement of breathlessness in advanced disease: a systematic review. Respir Med 2007; 101: 399–410.

26.

26 Zhao I Yates P . Non-pharmacological interventions for breathlessness management in patients with lung cancer: a systematic review. Palliat Med 2008; 22: 693–701.

27.

27 Abramson M Crockett A Frith P McDonald C . COPDX: an update of guidelines for the management of chronic obstructive pulmonary disease with a review of recent evidence. Med J Aust 2006; 184: 342–345.

28.

28 Currow DC Abernethy AP Fazekas BS . Oxygen use – patients define symptomatic benefit discerningly. J Pain Symptom Manage 2007; 34: 113–114.

29.

29 Currow DC Abernethy AP Fazekas BS . Specialist palliative care needs of whole populations. A feasibility study using a novel approach. Palliat Med 2004; 18: 239–247.

30.

30 McNamara B Rosenwax L Holman C . A method for defining and estimating the palliative care population. J Pain Symptom Manage 2006; 32: 5–12.

31.

31 Moody L McMillan S . Dyspnea and quality of life indicators in hospice patients and their caregivers. Health Qual Life Outcomes 2003; 1: 9–17.

32.

32 Currow D Christou T Smith J Carmody S Lewin G Aoun S . Do terminally ill people who live alone miss out on home oxygen treatment? An hypothesis generating study. J Palliat Med 2008; 11: 1015–1022.

33.

33 Abernethy AP Currow DC Frith P . Prescription of palliative oxygen: a clinician survey of expected benefit and patterns of use. J Palliat Care 2004; 20: 303–307.

34.

34 Stringer E McFarlane C Hernandez P . Physician practices for prescribing supplemental oxygen in the palliative care setting. J Palliat Care 2004; 20: 303–307.